$13.78
-0.25-1.78%
In chiusura: -
$14.05
0.271.96%
After hour: 7:08 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading NovoCure. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni NovoCure.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli NovoCure Ltd addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 8, 2025, Cordova Ashley, l'azienda CHIEF EXECUTIVE OFFICER purchased 81.55K condivisioni per $12.22 ciascuna.
- Il giorno luglio 30, 2025, Brackmann Christoph, l'azienda CHIEF FINANCIAL OFFICER purchased 20K condivisioni per $11.59 ciascuna.
Statistiche sulla proprietà per NovoCure Ltd
Numero di azioni emesse
111.799M
Azioni possedute dagli insider
10.325M
Percentuale posseduta dagli Insider
9.24%
Azioni possedute dagli investitori istituzionali
64.406M
Percentuale posseduta dagli investitori istituzionali
57.6%
Sep 08, 2025 | CHIEF EXECUTIVE OFFICER | 81.55K | $12.22 | $996.86K | BUY | 22.91% | 437.57K | Sep 05 | ||
Jul 30, 2025 | CHIEF FINANCIAL OFFICER | 20.00K | $11.59 | $231.80K | BUY | 16.51% | 141.15K | Jul 29 | ||
Jun 04, 2025 | — | -999.00 | $17.28 | -$17.26K | SELL | -24.65% | 3.05K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.31 | -$17.30K | SELL | -1.21% | 81.23K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.19 | -$17.18K | SELL | -5.08% | 18.67K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.32 | -$17.30K | SELL | -14.24% | 6.02K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.26 | -$17.25K | SELL | -15.16% | 5.59K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.29 | -$17.27K | SELL | -24.65% | 3.05K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.35 | -$17.33K | SELL | -0.59% | 167.89K | Jun 03 | ||
Jun 04, 2025 | — | -999.00 | $17.30 | -$17.28K | SELL | -7.57% | 12.20K | Jun 03 | ||
Jun 04, 2025 | EVP, PRES., NOVOCURE ONCOLOGY | -30.20K | $17.50 | -$528.41K | SELL | -15.20% | 168.45K | Jun 02 | ||
May 05, 2025 | CHIEF OPERATING OFFICER | -592.00 | $17.91 | -$10.60K | SELL | -0.70% | 83.56K | May 03 | ||
Mar 04, 2025 | CHIEF INNOVATION OFFICER | -268.00 | $18.92 | -$5.07K | SELL | -0.16% | 166.24K | Mar 03 | ||
Mar 04, 2025 | EVP, PRES., NOVOCURE ONCOLOGY | -2.53K | $18.54 | -$46.84K | SELL | -1.73% | 143.67K | Mar 03 | ||
Mar 04, 2025 | CHIEF EXECUTIVE OFFICER | -2.05K | $18.54 | -$38.06K | SELL | -1.00% | 204.00K | Mar 03 | ||
Mar 04, 2025 | CHIEF OPERATING OFFICER | -250.00 | $18.54 | -$4.63K | SELL | -0.85% | 29.17K | Mar 03 | ||
Mar 03, 2025 | CHIEF INNOVATION OFFICER | -4.64K | $18.75 | -$86.95K | SELL | -2.71% | 166.51K | Feb 28 | ||
Mar 03, 2025 | CHIEF MEDICAL OFFICER | -991.00 | $20.02 | -$19.84K | SELL | -1.94% | 50.13K | Feb 27 | ||
Mar 03, 2025 | CHIEF HUMAN RESOURCES OFFICER | -1.39K | $20.02 | -$27.77K | SELL | -1.26% | 108.71K | Feb 27 | ||
Mar 03, 2025 | EVP, PRES., NOVOCURE ONCOLOGY | -15.04K | $19.70 | -$296.26K | SELL | -9.33% | 146.20K | Feb 27 - Feb 28 | ||
Mar 03, 2025 | CHIEF EXECUTIVE OFFICER | -13.49K | $19.72 | -$266.13K | SELL | -6.15% | 206.06K | Feb 27 - Feb 28 | ||
Mar 03, 2025 | CHIEF OPERATING OFFICER | -2.01K | $19.71 | -$39.69K | SELL | -6.41% | 29.42K | Feb 27 - Feb 28 | ||
Jan 15, 2025 | CHIEF OPERATING OFFICER | -2.16K | $26.81 | -$57.91K | SELL | -6.43% | 31.44K | Jan 11 | ||
Nov 06, 2024 | CHIEF OPERATING OFFICER | 30.09K | $16.69 | -$734.18 | GRANT | 859.09% | 33.60K | Nov 02 - Nov 04 | ||
Nov 04, 2024 | CHIEF HUMAN RESOURCES OFFICER | -810.00 | $15.79 | -$12.79K | SELL | -0.73% | 110.09K | Oct 31 | ||
Nov 04, 2024 | EVP, PRES., NOVOCURE ONCOLOGY | -598.00 | $15.94 | -$9.53K | SELL | -0.37% | 161.24K | Nov 01 | ||
Nov 04, 2024 | CHIEF OPERATING OFFICER | -160.00 | $15.88 | -$2.54K | SELL | -4.37% | 3.50K | Nov 01 | ||
Aug 05, 2024 | CHIEF FINANCIAL OFFICER | -688.00 | $20.14 | -$13.86K | SELL | -0.31% | 219.18K | Aug 02 | ||
Jun 06, 2024 | — | 3.09K | $23.89 | -$23.03K | GRANT | 1.85% | 169.85K | Jun 04 - Jun 05 | ||
Jun 06, 2024 | — | 3.09K | $23.89 | -$23.03K | GRANT | 63.14% | 7.98K | Jun 04 - Jun 05 | ||
Jun 06, 2024 | — | 3.09K | $23.89 | -$23.03K | GRANT | 3.86% | 83.19K | Jun 04 - Jun 05 | ||
Mar 05, 2024 | CHIEF OPERATING OFFICER | -3.32K | $16.02 | -$53.25K | SELL | -1.31% | 251.24K | Mar 01 - Mar 04 | ||
Mar 05, 2024 | EVP, PRES., NOVOCURE ONCOLOGY | -2.52K | $16.02 | -$40.36K | SELL | -1.55% | 160.10K | Mar 01 - Mar 04 | ||
Feb 29, 2024 | EVP, PRES., NOVOCURE ONCOLOGY | 100.17K | $16.22 | $1.63M | GRANT | 160.41% | 162.62K | Feb 27 - Feb 28 | ||
Feb 29, 2024 | CHIEF OPERATING OFFICER | 44.73K | $16.22 | $729.52K | GRANT | 21.32% | 254.56K | Dec 31 - Feb 28 | ||
Nov 08, 2023 | CHIEF GROWTH OFFICER | -382.00 | $12.65 | -$4.83K | SELL | -0.31% | 124.51K | Nov 07 | ||
Sep 05, 2023 | CHIEF FINANCIAL OFFICER | -883.00 | $21.82 | -$19.26K | SELL | -0.88% | 99.65K | Sep 01 | ||
Sep 05, 2023 | CHIEF OPERATING OFFICER | -294.00 | $21.82 | -$6.41K | SELL | -0.14% | 209.82K | Sep 01 | ||
Sep 05, 2023 | CHIEF GROWTH OFFICER | -273.00 | $21.82 | -$5.96K | SELL | -0.22% | 124.89K | Sep 01 | ||
Aug 04, 2023 | CHIEF FINANCIAL OFFICER | -1.14K | $30.25 | -$34.61K | SELL | -1.13% | 100.53K | Aug 02 | ||
Mar 07, 2023 | PRESIDENT, CNS CANCERS US | -13.61K | $75.55 | -$1.03M | SELL | -20.04% | 54.28K | Mar 03 - Mar 07 | ||
Mar 07, 2023 | CHIEF GROWTH OFFICER | -21.42K | $76.16 | -$1.63M | SELL | -14.65% | 124.80K | Mar 03 | ||
Mar 07, 2023 | CHIEF OPERATING OFFICER | -25.64K | $76.16 | -$1.95M | SELL | -10.89% | 209.75K | Mar 03 | ||
Mar 07, 2023 | CHIEF FINANCIAL OFFICER | -5.50K | $76.16 | -$419.26K | SELL | -5.15% | 101.31K | Mar 03 | ||
Mar 07, 2023 | CHIEF HUMAN RESOURCES OFFICER | -593.00 | $76.16 | -$45.16K | SELL | -0.89% | 66.09K | Mar 03 | ||
Mar 06, 2023 | CHIEF HUMAN RESOURCES OFFICER | -281.00 | $75.28 | -$21.15K | SELL | -0.42% | 66.68K | Mar 02 | ||
Mar 06, 2023 | CHIEF GROWTH OFFICER | 46.24K | $75.28 | -$70.54K | GRANT | 46.26% | 146.22K | Mar 02 - Mar 03 | ||
Mar 06, 2023 | CHIEF OPERATING OFFICER | 50.77K | $75.28 | -$91.31K | GRANT | 27.50% | 235.39K | Mar 02 - Mar 03 | ||
Mar 06, 2023 | CHIEF FINANCIAL OFFICER | 10.75K | $75.28 | -$79.42K | GRANT | 11.19% | 106.81K | Mar 02 - Mar 03 | ||
Mar 06, 2023 | PRESIDENT, CNS CANCERS US | 8.90K | $76.95 | -$223.39K | GRANT | 15.10% | 67.89K | Mar 02 - Mar 03 | ||
Mar 03, 2023 | PRESIDENT, CNS CANCERS US | -4.11K | $75.38 | -$309.58K | SELL | -6.51% | 58.99K | Mar 02 | ||
Mar 02, 2023 | PRESIDENT, CNS CANCERS US | 16.94K | $76.36 | -$128.59K | GRANT | 36.69% | 63.09K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | CHIEF GROWTH OFFICER | 17.13K | $76.36 | -$146.84K | GRANT | 20.68% | 99.97K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | CHIEF FINANCIAL OFFICER | 21.62K | $76.36 | -$167.84K | GRANT | 29.04% | 96.06K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | CHIEF HUMAN RESOURCES OFFICER | 11.37K | $76.36 | -$57.65K | GRANT | 20.45% | 66.96K | Feb 28 - Mar 01 | ||
Mar 02, 2023 | CHIEF OPERATING OFFICER | 19.49K | $76.36 | -$165.25K | GRANT | 11.80% | 184.62K | Feb 28 - Mar 01 | ||
Jan 09, 2023 | CHIEF SCIENCE OFFICER | -6.20K | $81.59 | -$854.22K | SELL | -12.52% | 43.29K | Jan 05 | ||
Jan 09, 2023 | PRESIDENT, CNS CANCERS US | -4.30K | $63.82 | -$3.89M | SELL | -8.52% | 46.16K | Jan 05 | ||
Jan 09, 2023 | CHIEF COMMERCIAL OFFICER | -387.00 | $108.00 | -$41.80K | SELL | -0.46% | 82.84K | Jan 05 | ||
Jan 09, 2023 | CHIEF EXECUTIVE OFFICER | 39.00 | $58.20 | -$21.48M | SELL-OPTIONS | 0.29% | 13.62K | Jan 05 - Jan 06 | ||
Oct 17, 2022 | PRESIDENT, CNS CANCERS US | -6.75K | $76.01 | -$513.37K | SELL | -13.41% | 43.63K | Oct 13 | ||
Oct 07, 2022 | PRESIDENT, CNS CANCERS US | -6.75K | $84.37 | -$569.83K | SELL | -11.82% | 50.38K | Oct 06 | ||
Sep 30, 2022 | PRESIDENT, CNS CANCERS US | -6.75K | $77.35 | -$522.42K | SELL | -10.57% | 57.13K | Sep 29 | ||
Sep 26, 2022 | PRESIDENT, CNS CANCERS US | -6.75K | $77.00 | -$520.06K | SELL | -9.56% | 63.89K | Sep 22 | ||
Sep 19, 2022 | CHIEF DEVELOPMENT OFFICER | -6.75K | $47.83 | -$1.05M | SELL | -8.73% | 70.64K | Sep 15 | ||
Sep 12, 2022 | CHIEF DEVELOPMENT OFFICER | -1.86K | $88.00 | -$163.94K | SELL | -2.17% | 84.15K | Sep 09 | ||
Sep 07, 2022 | CHIEF DEVELOPMENT OFFICER | -1.38K | $78.57 | -$108.74K | SELL | -1.58% | 86.01K | Sep 06 | ||
Sep 06, 2022 | CHIEF HUMAN RESOURCES OFFICER | -718.00 | $79.04 | -$56.75K | SELL | -1.28% | 55.49K | Sep 02 | ||
Sep 06, 2022 | CHIEF FINANCIAL OFFICER | -885.00 | $79.04 | -$69.95K | SELL | -1.21% | 72.38K | Sep 02 | ||
Sep 06, 2022 | CHIEF OPERATING OFFICER | -296.00 | $79.04 | -$23.39K | SELL | -0.18% | 165.02K | Sep 02 | ||
Sep 06, 2022 | CHIEF COMMERCIAL OFFICER | -269.00 | $79.04 | -$21.26K | SELL | -0.32% | 83.23K | Sep 02 | ||
Sep 06, 2022 | CHIEF DEVELOPMENT OFFICER | -14.80K | $77.50 | -$1.15M | SELL | -14.48% | 87.40K | Sep 01 - Sep 02 | ||
Aug 04, 2022 | CHIEF MEDICAL OFFICER | -5.96K | $73.73 | -$439.33K | SELL | -17.21% | 28.67K | Aug 03 | ||
Aug 03, 2022 | EXECUTIVE CHAIRMAN | -837.00 | $69.66 | -$58.30K | SELL | -0.15% | 551.18K | Aug 02 | ||
Aug 03, 2022 | CHIEF MEDICAL OFFICER | -437.00 | $69.66 | -$30.44K | SELL | -1.25% | 34.63K | Aug 02 | ||
Aug 03, 2022 | CHIEF DEVELOPMENT OFFICER | -414.00 | $69.66 | -$28.84K | SELL | -0.40% | 102.19K | Aug 02 | ||
Jun 16, 2022 | DIRECTOR | -407.00 | $69.61 | -$28.33K | SELL | -13.82% | 2.54K | Jun 10 | ||
May 12, 2022 | CHIEF MEDICAL OFFICER | -4.21K | $63.17 | -$265.65K | SELL | -10.77% | 34.85K | May 10 - May 11 | ||
Mar 11, 2022 | CHIEF COMMERCIAL OFFICER | 48.00 | $112.60 | $311.26K | SELL-OPTIONS | 0.06% | 83.19K | Jul 31 - Mar 09 | ||
Mar 09, 2022 | CHIEF COMMERCIAL OFFICER | -7.78K | $69.73 | -$542.12K | SELL | -8.67% | 81.91K | Mar 07 - Mar 08 | ||
Mar 09, 2022 | CHIEF DEVELOPMENT OFFICER | -744.00 | $70.10 | -$52.15K | SELL | -0.72% | 102.30K | Mar 08 | ||
Mar 09, 2022 | CHIEF HUMAN RESOURCES OFFICER | -1.04K | $70.10 | -$72.69K | SELL | -1.82% | 55.99K | Mar 08 | ||
Mar 09, 2022 | CHIEF OPERATING OFFICER | -2.92K | $70.10 | -$204.90K | SELL | -1.74% | 165.10K | Mar 08 | ||
Mar 09, 2022 | CHIEF FINANCIAL OFFICER | -759.00 | $70.10 | -$53.21K | SELL | -1.23% | 60.85K | Mar 08 | ||
Mar 09, 2022 | GENERAL COUNSEL | -2.34K | $70.10 | -$163.96K | SELL | -3.61% | 62.46K | Mar 08 | ||
Mar 09, 2022 | EXECUTIVE CHAIRMAN | -2.38K | $70.10 | -$167.19K | SELL | -0.43% | 552.01K | Mar 08 | ||
Mar 07, 2022 | GENERAL COUNSEL | -3.07K | $71.87 | -$220.41K | SELL | -4.52% | 64.80K | Mar 03 - Mar 04 | ||
Mar 07, 2022 | CHIEF FINANCIAL OFFICER | 19.80K | $73.16 | -$124.74K | GRANT | 47.37% | 61.61K | Mar 03 - Mar 04 | ||
Mar 07, 2022 | CHIEF COMMERCIAL OFFICER | 16.17K | $72.54 | -$402.06K | GRANT | 22.00% | 89.68K | Mar 03 - Mar 04 | ||
Mar 07, 2022 | CHIEF MEDICAL OFFICER | 15.06K | $71.83 | -$166.14K | GRANT | 53.40% | 43.26K | Mar 03 - Mar 04 | ||
Mar 07, 2022 | CHIEF HUMAN RESOURCES OFFICER | 6.08K | $71.43 | -$97.64K | GRANT | 11.93% | 57.03K | Mar 03 - Mar 04 | ||
Mar 07, 2022 | CHIEF OPERATING OFFICER | 18.05K | $71.78 | -$277.80K | GRANT | 12.04% | 168.03K | Mar 03 - Mar 04 | ||
Mar 07, 2022 | CHIEF DEVELOPMENT OFFICER | 15.89K | $72.97 | -$108.36K | GRANT | 18.23% | 103.04K | Mar 03 - Mar 04 | ||
Jan 05, 2022 | CHIEF HUMAN RESOURCES OFFICER | 24.65K | $43.24 | -$266.98 | SELL-OPTIONS | 94.03% | 50.87K | Jan 03 | ||
Nov 29, 2021 | CHIEF EXECUTIVE OFFICER | 4.97K | $102.44 | $509.54K | BUY | 59.91% | 13.28K | Nov 26 | ||
Nov 03, 2021 | CHIEF FINANCIAL OFFICER | -209.00 | $107.28 | -$22.42K | SELL | -0.50% | 41.76K | Nov 02 | ||
Sep 07, 2021 | CHIEF DEVELOPMENT OFFICER | -540.00 | $138.23 | -$74.65K | SELL | -0.62% | 87.15K | Sep 02 | ||
Sep 07, 2021 | CHIEF FINANCIAL OFFICER | -828.00 | $138.23 | -$114.46K | SELL | -1.93% | 41.97K | Sep 02 | ||
Sep 07, 2021 | CHIEF OPERATING OFFICER | -181.00 | $138.23 | -$25.02K | SELL | -0.12% | 149.90K | Sep 02 | ||
Sep 07, 2021 | CHIEF COMMERCIAL OFFICER | -657.00 | $138.57 | -$91.04K | SELL | -0.89% | 73.51K | Sep 02 - Sep 03 | ||
Aug 16, 2021 | CHIEF FINANCIAL OFFICER | 8.27K | $84.88 | -$2.70M | SELL-OPTIONS | 22.97% | 44.26K | Aug 12 | ||
Aug 06, 2021 | DIRECTOR | -34.00 | $153.13 | -$5.21K | SELL | -0.21% | 16.00K | Aug 05 | ||
Aug 06, 2021 | CHIEF COMMERCIAL OFFICER | -2.06K | $148.71 | -$306.79K | SELL | -2.71% | 74.17K | Aug 04 | ||
Aug 06, 2021 | DIRECTOR | 0.00 | $91.97 | -$121.05K | SELL-OPTIONS | 0.00% | 72.86K | Aug 05 | ||
Aug 04, 2021 | CHIEF DEVELOPMENT OFFICER | -1.04K | $149.39 | -$155.52K | SELL | -1.15% | 89.16K | Aug 02 - Aug 03 | ||
Aug 04, 2021 | CHIEF COMMERCIAL OFFICER | -1.65K | $149.43 | -$247.16K | SELL | -2.12% | 76.23K | Aug 03 | ||
Aug 04, 2021 | EXECUTIVE CHAIRMAN | -995.00 | $149.38 | -$148.63K | SELL | -0.18% | 554.40K | Aug 02 | ||
Aug 04, 2021 | CHIEF MEDICAL OFFICER | -464.00 | $150.11 | -$69.65K | SELL | -1.62% | 28.14K | Aug 03 | ||
Aug 03, 2021 | CHIEF MEDICAL OFFICER | -536.00 | $118.97 | -$129.32K | SELL | -1.84% | 28.61K | Jul 30 - Aug 02 | ||
Jul 08, 2021 | DIRECTOR | 0.00 | $107.49 | -$152.09K | SELL-OPTIONS | 0.00% | 72.86K | Jul 06 | ||
Jun 11, 2021 | CHIEF COMMERCIAL OFFICER | -23.54K | $215.00 | -$5.06M | SELL | -23.24% | 77.73K | Jun 10 | ||
Jun 08, 2021 | DIRECTOR | 0.00 | $118.00 | -$173.10K | SELL-OPTIONS | 0.00% | 72.05K | Jun 07 | ||
May 28, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $123.78 | -$279.42K | SELL-OPTIONS | 0.00% | 29.05K | May 27 | ||
May 14, 2021 | CHIEF MEDICAL OFFICER | -1.94K | $180.48 | -$350.67K | SELL | -6.27% | 29.05K | May 12 | ||
May 12, 2021 | CHIEF MEDICAL OFFICER | -2.26K | $115.97 | -$667.88K | SELL | -6.80% | 31.00K | May 10 - May 11 | ||
May 12, 2021 | CHIEF SCIENCE OFFICER | -1.80K | $118.61 | -$888.61K | SELL | -5.39% | 31.67K | May 10 | ||
May 06, 2021 | CHIEF COMMERCIAL OFFICER | -1.29K | $199.67 | -$257.57K | SELL | -1.26% | 101.27K | May 05 | ||
May 06, 2021 | DIRECTOR | 0.00 | $115.56 | -$168.22K | SELL-OPTIONS | 0.00% | 72.05K | May 05 | ||
May 05, 2021 | CHIEF COMMERCIAL OFFICER | 1.29K | $202.48 | $266.67K | SELL-OPTIONS | 1.27% | 102.56K | May 03 - May 04 | ||
Apr 15, 2021 | EXECUTIVE CHAIRMAN | -95.00K | $199.55 | -$18.96M | SELL | -14.61% | 555.39K | Apr 13 | ||
Apr 15, 2021 | CHIEF EXECUTIVE OFFICER | -97.97K | $196.34 | -$19.24M | SELL | -92.29% | 8.18K | Apr 13 | ||
Apr 15, 2021 | DIRECTOR | 0.00 | $115.14 | -$1.00M | SELL-OPTIONS | 0.00% | 72.05K | Apr 13 | ||
Apr 15, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $132.09 | -$809.20K | SELL-OPTIONS | 0.00% | 33.26K | Apr 13 | ||
Apr 08, 2021 | CHIEF OPERATING OFFICER | -3.67K | $72.22 | -$265.03K | SELL | -2.39% | 150.01K | Feb 28 | ||
Apr 02, 2021 | EXECUTIVE CHAIRMAN | 1.33K | $129.69 | $96.39K | SELL-OPTIONS | 0.21% | 650.39K | Mar 31 - Apr 01 | ||
Mar 25, 2021 | CHIEF SCIENCE OFFICER | 0.00 | $93.52 | -$361.80K | SELL-OPTIONS | 0.00% | 36.31K | Mar 23 | ||
Mar 10, 2021 | CHIEF COMMERCIAL OFFICER | -6.15K | $130.97 | -$805.59K | SELL | -5.73% | 101.27K | Mar 08 - Mar 09 | ||
Mar 10, 2021 | CHIEF FINANCIAL OFFICER | -765.00 | $130.81 | -$100.07K | SELL | -2.09% | 35.89K | Mar 08 | ||
Mar 10, 2021 | GENERAL COUNSEL | -2.40K | $130.81 | -$314.46K | SELL | -3.43% | 67.71K | Mar 08 | ||
Mar 10, 2021 | CHIEF DEVELOPMENT OFFICER | -765.00 | $130.81 | -$100.07K | SELL | -0.84% | 90.05K | Mar 08 | ||
Mar 10, 2021 | CHIEF OPERATING OFFICER | -3.00K | $130.81 | -$392.94K | SELL | -1.92% | 153.68K | Mar 08 | ||
Mar 09, 2021 | CHIEF COMMERCIAL OFFICER | 9.44K | $69.34 | -$498.45K | SELL-OPTIONS | 9.63% | 107.42K | Mar 05 | ||
Mar 09, 2021 | CHIEF MEDICAL OFFICER | -2.92K | $131.53 | -$383.80K | SELL | -8.07% | 33.26K | Mar 05 | ||
Mar 08, 2021 | CHIEF OPERATING OFFICER | -3.85K | $137.55 | -$530.13K | SELL | -2.40% | 156.69K | Mar 04 | ||
Mar 08, 2021 | GENERAL COUNSEL | -3.08K | $137.55 | -$424.22K | SELL | -4.21% | 70.12K | Mar 04 | ||
Mar 08, 2021 | CHIEF DEVELOPMENT OFFICER | -567.00 | $137.55 | -$77.99K | SELL | -0.62% | 90.81K | Mar 04 | ||
Mar 08, 2021 | CHIEF FINANCIAL OFFICER | -1.48K | $137.55 | -$77.99K | SELL | -3.87% | 36.66K | Mar 04 | ||
Mar 05, 2021 | CHIEF MEDICAL OFFICER | -1.89K | $107.75 | -$542.60K | SELL | -4.96% | 36.18K | Mar 03 - Mar 04 | ||
Mar 05, 2021 | CHIEF COMMERCIAL OFFICER | -4.83K | $143.50 | -$693.41K | SELL | -4.70% | 97.99K | Mar 03 - Mar 04 | ||
Mar 04, 2021 | CHIEF DEVELOPMENT OFFICER | 8.28K | $152.05 | -$65.38K | GRANT | 9.96% | 91.38K | Mar 02 | ||
Mar 04, 2021 | CHIEF FINANCIAL OFFICER | 10.46K | $152.05 | -$65.08K | GRANT | 37.79% | 38.13K | Mar 02 | ||
Mar 04, 2021 | CHIEF OPERATING OFFICER | 10.13K | $152.05 | -$363.71K | GRANT | 6.73% | 160.54K | Mar 02 | ||
Mar 04, 2021 | CHIEF COMMERCIAL OFFICER | 9.97K | $152.05 | -$138.67K | GRANT | 10.74% | 102.82K | Mar 02 | ||
Mar 04, 2021 | GENERAL COUNSEL | 7.99K | $152.05 | -$358.08K | GRANT | 12.25% | 73.20K | Mar 02 | ||
Feb 24, 2021 | CHIEF SCIENCE OFFICER | 0.00 | $91.33 | -$1.09M | SELL-OPTIONS | 0.00% | 27.60K | Feb 22 | ||
Jan 19, 2021 | GENERAL COUNSEL | -27.42K | $93.43 | -$10.48M | SELL | -31.49% | 59.66K | Jan 15 | ||
Dec 22, 2020 | — | 0.00 | $106.82 | -$247.86K | OPTION EXERCISE | 0.00% | 29.36K | Dec 21 | ||
Dec 22, 2020 | — | -2.50K | $166.40 | -$416.00K | SELL | -42.37% | 3.40K | Dec 18 | ||
Dec 22, 2020 | — | 0.00 | $89.69 | -$28.15M | OPTION EXERCISE | 0.00% | 197.63K | Dec 18 | ||
Nov 03, 2020 | — | -230.00 | $117.41 | -$27.00K | SELL | -0.87% | 26.21K | Nov 02 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.